Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| ABIVAX Société Anonyme(ABVX) | 1,394,019 | 1,804,703 | +410,684 | $155.22M | $240.49M | 11.30% | +$85.27M |
| PROTAGONIST THERAPEUTICS INC | 994,119 | 960,863 | -33,256 | $104.78M | $117.78M | 5.54% | +$13.00M |
| Roivant Sciences Ltd.(ROIV) | 3,285,906 | 3,157,008 | -128,898 | $91.02M | $111.73M | 5.25% | +$20.71M |
| State Street SPDR S&P 500 ETF Trust(SPY) | 75,940 | 129,087 | +53,147 | $49.39M | $96.40M | 4.53% | +$47.01M |
| Immunovant, Inc.(IMVT) | 2,679,010 | 2,330,716 | -348,294 | $66.55M | $89.80M | 4.22% | +$23.26M |
| Zai Lab Limited(ZLAB) | 1,425,367 | 3,369,034 | +1,943,667 | $26.81M | $64.01M | 3.01% | +$37.20M |
| Agios Pharmaceuticals, Inc.(AGIO) | 140,672 | 1,288,053 | +1,147,381 | $4.76M | $47.80M | 2.25% | +$43.04M |
| CRINETICS PHARMACEUTICALS IN | 1,139,331 | 1,222,080 | +82,749 | $41.38M | $45.73M | 2.15% | +$4.35M |
| EA SERIES TRUST ALPHA ARCH 1-3 | 337,125 | 337,125 | 0 | $39.20M | $39.47M | 1.86% | +$269.7K |
| Cytokinetics, Incorporated(CYTK) | 632,556 | 457,907 | -174,649 | $41.69M | $39.01M | 1.83% | -$2.68M |
| Septerna, Inc.(SEPN) | 1,089,818 | 940,747 | -149,071 | $26.19M | $31.51M | 1.48% | +$5.32M |
| ANTERIS TECHNOLOGIES GLOBAL | 3,789,132 | 3,145,096 | -644,036 | $21.03M | $30.98M | 1.46% | +$9.95M |
| EDITAS MEDICINE INC | 0 | 8,889,000 | +8,889,000 | $0 | $28.80M | 1.35% | +$28.80M |
| Denali Therapeutics Inc.(DNLI) | 1,871,455 | 1,029,080 | -842,375 | $35.93M | $26.47M | 1.24% | -$9.46M |
| Spyre Therapeutics, Inc.(SYRE) | 338,323 | 283,982 | -54,341 | $17.07M | $25.21M | 1.19% | +$8.15M |
| Vir Biotechnology, Inc.(VIR) | 2,744,714 | 2,456,677 | -288,037 | $24.59M | $25.03M | 1.18% | +$440.9K |
| Praxis Precision Medicines, Inc.(PRAX) | 1,500 | 74,253 | +72,753 | $483.3K | $24.86M | 1.17% | +$24.38M |
| Insmed Incorporated(INSM) | 35,392 | 228,520 | +193,128 | $5.79M | $24.36M | 1.15% | +$18.58M |
| Celldex Therapeutics, Inc.(CLDX) | 427,816 | 619,542 | +191,726 | $13.57M | $23.05M | 1.08% | +$9.48M |
| Viking Therapeutics, Inc.(VKTX) | 227,717 | 574,038 | +346,321 | $7.41M | $22.39M | 1.05% | +$14.98M |
| Taysha Gene Therapies, Inc.(TSHA) | 2,979,429 | 3,040,466 | +61,037 | $13.32M | $20.71M | 0.97% | +$7.39M |
| MONOPAR THERAPEUTICS INC | 264,278 | 217,595 | -46,683 | $14.48M | $20.15M | 0.95% | +$5.67M |
| OVID THERAPEUTICS INC | 4,544,113 | 7,417,479 | +2,873,366 | $10.09M | $19.95M | 0.94% | +$9.87M |
| ENLIVEN THERAPEUTICS INC | 329,540 | 387,718 | +58,178 | $12.92M | $19.68M | 0.92% | +$6.76M |
| ENANTA PHARMACEUTICALS INC | 51,357 | 1,344,510 | +1,293,153 | $648.6K | $19.60M | 0.92% | +$18.95M |
| Nektar Therapeutics(NKTR) | 161,252 | 244,184 | +82,932 | $11.60M | $17.05M | 0.80% | +$5.44M |
| Inspire Medical Systems, Inc.(INSP) | 405,197 | 374,617 | -30,580 | $20.90M | $16.71M | 0.79% | -$4.19M |
| Revolution Medicines, Inc.(RVMD) | 133,893 | 87,509 | -46,384 | $13.02M | $16.39M | 0.77% | +$3.37M |
| Establishment Labs Holdings Inc.(ESTA) | 213,473 | 185,619 | -27,854 | $12.12M | $15.93M | 0.75% | +$3.81M |
| PROTHENA CORP PLC SHS | 1,581,443 | 1,554,535 | -26,908 | $15.37M | $15.22M | 0.72% | -$152.7K |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 211,450 | 136,158 | -75,292 | $18.39M | $15.12M | 0.71% | -$3.27M |
| INHIBIKASE THERAPEUTICS INC | 6,606,572 | 7,387,205 | +780,633 | $11.10M | $15.00M | 0.70% | +$3.90M |
| uniQure N.V.(QURE) | 76,206 | 324,672 | +248,466 | $1.25M | $14.95M | 0.70% | +$13.71M |
| RALLYBIO CORP | 20,535 | 926,352 | +905,817 | $184.2K | $14.82M | 0.70% | +$14.64M |
| Regeneron Pharmaceuticals, Inc.(REGN) | 12,154 | 22,208 | +10,054 | $9.39M | $13.85M | 0.65% | +$4.46M |
| INVENTIVA SA | 2,174,398 | 3,606,656 | +1,432,258 | $12.07M | $13.63M | 0.64% | +$1.57M |
| SUTRO BIOPHARMA INC | 524,441 | 404,014 | -120,427 | $13.06M | $13.41M | 0.63% | +$349.4K |
| Ionis Pharmaceuticals, Inc.(IONS) | 160,338 | 166,286 | +5,948 | $12.04M | $13.18M | 0.62% | +$1.15M |
| BridgeBio Pharma, Inc.(BBIO) | 94,292 | 176,689 | +82,397 | $7.00M | $13.16M | 0.62% | +$6.16M |
| Sarepta Therapeutics, Inc.(SRPT) | 262,058 | 730,649 | +468,591 | $5.70M | $13.13M | 0.62% | +$7.43M |
| CYTOMX THERAPEUTICS INC. | 3,410,190 | 3,365,118 | -45,072 | $16.03M | $12.62M | 0.59% | -$3.41M |
| Vor Biopharma Inc.(VOR) | 0 | 680,626 | +680,626 | $0 | $12.53M | 0.59% | +$12.53M |
| SPDR SERIES TRUST ST STR BLO 1 ETF | 135,585 | 135,585 | 0 | $12.43M | $12.43M | 0.58% | $0 |
| EQUILLIUM INC | 3,726,659 | 3,758,569 | +31,910 | $7.45M | $12.03M | 0.57% | +$4.57M |
| Adlai Nortye Group Ltd.(ANL) | 117,909 | 1,017,805 | +899,896 | $815.9K | $11.70M | 0.55% | +$10.89M |
| CLIMB BIO INC | 597,662 | 822,649 | +224,987 | $4.09M | $10.73M | 0.50% | +$6.63M |
| HELIX ACQUISITION CORP III | 1,000,000 | 1,000,000 | 0 | $10.30M | $10.60M | 0.50% | +$300.0K |
| ZURA BIO LTD | 630,403 | 1,759,295 | +1,128,892 | $3.75M | $10.38M | 0.49% | +$6.63M |
| ONKURE THERAPEUTICS INC | 2,434,941 | 2,238,684 | -196,257 | $10.08M | $10.21M | 0.48% | +$127.7K |
| Maze Therapeutics, Inc.(MAZE) | 50,095 | 339,276 | +289,181 | $1.50M | $10.12M | 0.48% | +$8.63M |
| Xenon Pharmaceuticals Inc.(XENE) | 228,899 | 166,550 | -62,349 | $13.31M | $10.05M | 0.47% | -$3.26M |
| Teva Pharmaceutical Industries Limited(TEVA) | 268,391 | 277,848 | +9,457 | $8.08M | $9.41M | 0.44% | +$1.33M |
| UroGen Pharma Ltd.(URGN) | 395,459 | 252,395 | -143,064 | $7.11M | $9.29M | 0.44% | +$2.18M |
| FAETH THERAPEUTICS INC | 0 | 361,010 | +361,010 | $0 | $9.03M | 0.42% | +$9.03M |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 1,000,604 | 494,378 | -506,226 | $13.91M | $8.88M | 0.42% | -$5.03M |
| DBV TECHNOLOGIES S A | 1,012,866 | 528,295 | -484,571 | $21.16M | $8.66M | 0.41% | -$12.49M |
| Savara Inc.(SVRA) | 1,464,535 | 1,403,409 | -61,126 | $8.00M | $8.64M | 0.41% | +$648.6K |
| Vaxcyte, Inc.(PCVX) | 259,137 | 146,034 | -113,103 | $15.06M | $8.49M | 0.40% | -$6.57M |
| CG Oncology, Inc.(CGON) | 185,699 | 118,664 | -67,035 | $12.57M | $8.43M | 0.40% | -$4.14M |
| Mineralys Therapeutics, Inc.(MLYS) | 154,686 | 298,886 | +144,200 | $4.19M | $8.06M | 0.38% | +$3.87M |
| Ascendis Pharma A/S(ASND) | 0 | 28,604 | +28,604 | $0 | $7.63M | 0.36% | +$7.63M |
| AMANAT ACQUISITION CORP | 0 | 750,000 | +750,000 | $0 | $7.62M | 0.36% | +$7.62M |
| Nurix Therapeutics, Inc.(NRIX) | 56,070 | 313,236 | +257,166 | $869.1K | $7.60M | 0.36% | +$6.73M |
| Biohaven Ltd.(BHVN) | 44,777 | 501,687 | +456,910 | $378.8K | $7.47M | 0.35% | +$7.09M |
| PRIME MEDICINE INC | 1,973,282 | 1,997,552 | +24,270 | $6.87M | $7.37M | 0.35% | +$503.9K |
| PERCEPTIVE CAP SOLUTIONS COR CL A ORD SHS | 499,581 | 674,695 | +175,114 | $5.48M | $7.34M | 0.35% | +$1.86M |
| OPUS GENETICS INC | 1,849,004 | 1,783,781 | -65,223 | $8.41M | $7.33M | 0.34% | -$1.08M |
| LEXEO THERAPEUTICS INC | 1,467,350 | 1,565,950 | +98,600 | $8.42M | $7.29M | 0.34% | -$1.13M |
| Damora Therapeutics, Inc.(DMRA) | 279,000 | 280,000 | +1,000 | $7.23M | $7.28M | 0.34% | +$56.7K |
| Replimune Group, Inc.(REPL) | 1,582,987 | 655,784 | -927,203 | $12.11M | $7.26M | 0.34% | -$4.85M |
| LEONABIO INC | 727,481 | 777,100 | +49,619 | $7.48M | $7.14M | 0.34% | -$337.0K |
| KORRO BIO INC | 540,054 | 540,054 | 0 | $6.11M | $7.12M | 0.33% | +$1.00M |
| RESEARCH ALLIANCE CORP III | 0 | 650,000 | +650,000 | $0 | $6.96M | 0.33% | +$6.96M |
| INFLARX NV | 158,271 | 3,000,000 | +2,841,729 | $141.6K | $6.72M | 0.32% | +$6.58M |
| Relay Therapeutics, Inc.(RLAY) | 0 | 358,333 | +358,333 | $0 | $6.70M | 0.32% | +$6.70M |
| Janux Therapeutics, Inc.(JANX) | 298,546 | 420,881 | +122,335 | $4.15M | $6.46M | 0.30% | +$2.31M |
| PLIANT THERAPEUTICS INC | 2,585,126 | 5,509,724 | +2,924,598 | $3.26M | $6.28M | 0.30% | +$3.02M |
| WHITEHAWK THERAPEUTICS INC | 128,503 | 1,341,394 | +1,212,891 | $443.3K | $6.14M | 0.29% | +$5.70M |
| Krystal Biotech, Inc.(KRYS) | 20,014 | 16,420 | -3,594 | $5.17M | $6.10M | 0.29% | +$932.8K |
| ARBUTUS BIOPHARMA CORP | 3,133,175 | 1,268,147 | -1,865,028 | $14.10M | $6.09M | 0.29% | -$8.01M |
| Pfizer Inc.(PFE) | 77,400 | 252,400 | +175,000 | $2.17M | $6.08M | 0.29% | +$3.90M |
| Brighthouse Financial, Inc.(BHF) | 95,523 | 95,523 | 0 | $5.72M | $6.05M | 0.28% | +$326.7K |
| Edgewise Therapeutics, Inc.(EWTX) | 90,599 | 143,199 | +52,600 | $2.85M | $5.82M | 0.27% | +$2.96M |
| ALECTOR INC | 1,050,000 | 2,883,583 | +1,833,583 | $2.26M | $5.80M | 0.27% | +$3.54M |
| FULCRUM THERAPEUTICS INC | 130,560 | 1,565,029 | +1,434,469 | $1.00M | $5.73M | 0.27% | +$4.73M |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 70,300 | 69,800 | -500 | $4.41M | $5.69M | 0.27% | +$1.28M |
| ACUMEN PHARMACEUTICALS INC | 2,156,334 | 2,111,334 | -45,000 | $5.09M | $5.64M | 0.26% | +$548.3K |
| OAKTREE ACQUISITION CORP III UNIT 10/04/2029 | 516,482 | 516,482 | 0 | $5.50M | $5.60M | 0.26% | +$98.1K |
| Globus Medical, Inc.(GMED) | 20,100 | 70,100 | +50,000 | $1.73M | $5.54M | 0.26% | +$3.81M |
| Monte Rosa Therapeutics, Inc.(GLUE) | 215,752 | 216,752 | +1,000 | $3.55M | $5.25M | 0.25% | +$1.70M |
| DISCIPLINED GROWTH | 0 | 500,000 | +500,000 | $0 | $5.02M | 0.24% | +$5.02M |
| BHAV ACQUISITION CORP | 495,000 | 495,000 | 0 | $4.93M | $5.00M | 0.24% | +$69.5K |
| BridgeBio Pharma, Inc.(BBIO) | 0 | 0 | 0 | $4.85M | $5.00M | 0.23% | +$147.1K |
| BridgeBio Pharma, Inc.(BBIO) | 0 | 0 | 0 | $4.94M | $4.94M | 0.23% | -$1.4K |
| Danaher Corporation(DHR) | 30,932 | 25,932 | -5,000 | $5.86M | $4.94M | 0.23% | -$925.2K |
| BOUNDLESS BIO INC | 0 | 1,968,216 | +1,968,216 | $0 | $4.92M | 0.23% | +$4.92M |
| AVALYN PHARMACEUTICALS INC | 0 | 146,447 | +146,447 | $0 | $4.82M | 0.23% | +$4.82M |
| ARS PHARMACEUTICALS INC | 1,361,536 | 600,999 | -760,537 | $10.93M | $4.81M | 0.23% | -$6.12M |
| ATAIBECKLEY INC | 913,242 | 913,242 | 0 | $3.23M | $4.81M | 0.23% | +$1.58M |
| PRELUDE THERAPEUTICS INC | 152,825 | 900,900 | +748,075 | $522.7K | $4.80M | 0.23% | +$4.28M |